165 related articles for article (PubMed ID: 37957619)
1. Juvenile dermatomyositis: association between nail fold capillary end row loop- area under the curve- and disease damage indicators.
Khojah A; Morgan G; Klein-Gitelman MS; Pachman LM
Pediatr Rheumatol Online J; 2023 Nov; 21(1):137. PubMed ID: 37957619
[TBL] [Abstract][Full Text] [Related]
2. Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators.
Khojah A; Morgan G; Klein-Gitelman MS; Pachman LM
Res Sq; 2023 Aug; ():. PubMed ID: 37674726
[TBL] [Abstract][Full Text] [Related]
3. Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity.
Pachman LM; Morgan G; Klein-Gitelman MS; Ahsan N; Khojah A
Pediatr Rheumatol Online J; 2023 Oct; 21(1):118. PubMed ID: 37828536
[TBL] [Abstract][Full Text] [Related]
4. Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study.
Xu D; Kacha-Ochana A; Morgan GA; Huang CC; Pachman LM
Pediatr Rheumatol Online J; 2017 May; 15(1):42. PubMed ID: 28514969
[TBL] [Abstract][Full Text] [Related]
5. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.
Smith RL; Sundberg J; Shamiyah E; Dyer A; Pachman LM
J Rheumatol; 2004 Aug; 31(8):1644-9. PubMed ID: 15290747
[TBL] [Abstract][Full Text] [Related]
6. Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.
Eimer MJ; Brickman WJ; Seshadri R; Ramsey-Goldman R; McPherson DD; Smulevitz B; Stone NJ; Pachman LM
J Pediatr; 2011 Nov; 159(5):795-801. PubMed ID: 21784434
[TBL] [Abstract][Full Text] [Related]
7. Association of p155/140 Autoantibody With Loss of Nailfold Capillaries but not Generalized Lipodystrophy: A Study of Ninety-Six Children With Juvenile Dermatomyositis.
Khojah A; Liu V; Savani SI; Morgan G; Shore R; Bellm J; Pachman LM
Arthritis Care Res (Hoboken); 2022 Jul; 74(7):1065-1069. PubMed ID: 33290639
[TBL] [Abstract][Full Text] [Related]
8. The family impact of caring for a child with juvenile dermatomyositis.
Kountz-Edwards S; Aoki C; Gannon C; Gomez R; Cordova M; Packman W
Chronic Illn; 2017 Dec; 13(4):262-274. PubMed ID: 28133992
[TBL] [Abstract][Full Text] [Related]
9. Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study.
Marstein HS; Witczak BN; Godang K; Olarescu NC; Schwartz T; Flatø B; Molberg Ø; Bollerslev J; Sjaastad I; Sanner H
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36828644
[TBL] [Abstract][Full Text] [Related]
10. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-10a Regulation of Proinflammatory Mediators: An Important Component of Untreated Juvenile Dermatomyositis.
Xu D; Huang CC; Kachaochana A; Morgan GA; Bonaldo MF; Soares MB; Costa F; Sarwark J; Sredni ST; Pachman LM
J Rheumatol; 2016 Jan; 43(1):161-8. PubMed ID: 26628598
[TBL] [Abstract][Full Text] [Related]
12. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.
Christen-Zaech S; Seshadri R; Sundberg J; Paller AS; Pachman LM
Arthritis Rheum; 2008 Feb; 58(2):571-6. PubMed ID: 18240225
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.
Roberson EDO; Mesa RA; Morgan GA; Cao L; Marin W; Pachman LM
Sci Rep; 2022 Jan; 12(1):275. PubMed ID: 34997119
[TBL] [Abstract][Full Text] [Related]
14. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
[TBL] [Abstract][Full Text] [Related]
15. Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease.
Scheja A; Elborgh R; Wildt M
J Rheumatol; 1999 Jun; 26(6):1377-81. PubMed ID: 10381059
[TBL] [Abstract][Full Text] [Related]
16. Juvenile dermatomyositis: extramuscular manifestations and their management.
Lowry CA; Pilkington CA
Curr Opin Rheumatol; 2009 Nov; 21(6):575-80. PubMed ID: 19730375
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Course of Patients with Juvenile Dermatomyositis - Case Series.
Rajarathinam I; Raghuram J; Rao AP
Neurol India; 2022; 70(1):300-303. PubMed ID: 35263900
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
Sharma A; Gupta A; Rawat A; Suri D; Singh S
Int J Rheum Dis; 2020 Mar; 23(3):392-396. PubMed ID: 31793219
[TBL] [Abstract][Full Text] [Related]
19. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
[TBL] [Abstract][Full Text] [Related]
20. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
Vuppala A; Sondhi M; Umer S
Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
